Загрузка...
SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer
Immunotherapeutic strategies including the blockade of programmed death 1 (PD-1) receptors hold promise for the treatment of various cancers including non-small cell lung carcinoma (NSCLC). Preclinical data suggest that pre-existing tumor immunity is important for disease regression upon checkpoint...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3782159/ https://ncbi.nlm.nih.gov/pubmed/24073380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.25205 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|